CLHC1
gene geneOn this page
Also known as FLJ31438
Summary
CLHC1 (clathrin heavy chain linker domain containing 1, HGNC:26453) is a protein-coding gene on chromosome 2p16.1, encoding Clathrin heavy chain linker domain-containing protein 1 (Q8NHS4).
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 121 total — 1 likely-pathogenic
- MANE Select transcript:
NM_152385
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:26453 |
| Approved symbol | CLHC1 |
| Name | clathrin heavy chain linker domain containing 1 |
| Location | 2p16.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ31438 |
| Ensembl gene | ENSG00000162994 |
| Ensembl biotype | protein_coding |
| Entrez | 130162 |
Gene structure
Transcript identifiers
Ensembl transcripts: 15 — 8 protein_coding, 5 protein_coding_CDS_not_defined, 2 nonsense_mediated_decay
ENST00000401408, ENST00000403506, ENST00000406076, ENST00000407122, ENST00000411884, ENST00000425841, ENST00000428621, ENST00000451916, ENST00000463300, ENST00000464243, ENST00000466020, ENST00000487320, ENST00000494539, ENST00000888022, ENST00000939099
RefSeq mRNA: 10 — MANE Select: NM_152385
NM_001135598, NM_001353779, NM_001353780, NM_001353781, NM_001353782, NM_001353783, NM_001353784, NM_001353786, NM_001353787, NM_152385
CCDS: CCDS33201, CCDS46287
Canonical transcript exons
ENST00000401408 — 13 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001209963 | 55209404 | 55209516 |
| ENSE00001209968 | 55209630 | 55209831 |
| ENSE00001210140 | 55232223 | 55232293 |
| ENSE00001354320 | 55228032 | 55228204 |
| ENSE00001507215 | 55208626 | 55208710 |
| ENSE00003504601 | 55206270 | 55206376 |
| ENSE00003538899 | 55222235 | 55222493 |
| ENSE00003556496 | 55212673 | 55212806 |
| ENSE00003565703 | 55177602 | 55177781 |
| ENSE00003653793 | 55217811 | 55217998 |
| ENSE00003673172 | 55180510 | 55180712 |
| ENSE00003694057 | 55181570 | 55181744 |
| ENSE00003842411 | 55172547 | 55175986 |
Expression profiles
Bgee: expression breadth ubiquitous, 186 present calls, max score 94.21.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 6.2064 / max 133.3829, expressed in 1602 samples.
FANTOM5 promoters (5 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 28444 | 5.4406 | 1550 |
| 28445 | 0.5313 | 282 |
| 28446 | 0.1506 | 68 |
| 28448 | 0.0435 | 13 |
| 28447 | 0.0403 | 9 |
Top tissues by expression
251 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right uterine tube | UBERON:0001302 | 94.21 | gold quality |
| sperm | CL:0000019 | 90.27 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 88.11 | gold quality |
| bronchial epithelial cell | CL:0002328 | 87.17 | gold quality |
| ventricular zone | UBERON:0003053 | 86.90 | gold quality |
| adrenal tissue | UBERON:0018303 | 86.88 | gold quality |
| adenohypophysis | UBERON:0002196 | 86.60 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 86.56 | gold quality |
| calcaneal tendon | UBERON:0003701 | 86.11 | gold quality |
| bronchus | UBERON:0002185 | 85.09 | gold quality |
| pituitary gland | UBERON:0000007 | 84.91 | gold quality |
| left testis | UBERON:0004533 | 83.70 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 83.47 | gold quality |
| right ovary | UBERON:0002118 | 83.37 | gold quality |
| ganglionic eminence | UBERON:0004023 | 83.35 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 83.29 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 83.27 | gold quality |
| right testis | UBERON:0004534 | 83.20 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 83.12 | gold quality |
| left ovary | UBERON:0002119 | 82.88 | gold quality |
| body of uterus | UBERON:0009853 | 82.65 | gold quality |
| body of pancreas | UBERON:0001150 | 82.45 | gold quality |
| thyroid gland | UBERON:0002046 | 82.43 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 82.37 | gold quality |
| testis | UBERON:0000473 | 82.34 | gold quality |
| cortical plate | UBERON:0005343 | 81.81 | gold quality |
| right adrenal gland | UBERON:0001233 | 81.75 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 81.14 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 80.91 | gold quality |
| stromal cell of endometrium | CL:0002255 | 80.87 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 6.54 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
105 targeting CLHC1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4776-3P | 100.00 | 68.73 | 1340 |
| HSA-MIR-6873-3P | 100.00 | 71.42 | 2626 |
| HSA-MIR-190A-3P | 100.00 | 80.35 | 5520 |
| HSA-MIR-29A-3P | 100.00 | 73.11 | 1835 |
| HSA-MIR-29B-3P | 100.00 | 73.18 | 1833 |
| HSA-MIR-29C-3P | 100.00 | 73.15 | 1833 |
| HSA-MIR-4795-3P | 100.00 | 74.62 | 4024 |
| HSA-MIR-126-5P | 100.00 | 72.71 | 3180 |
| HSA-MIR-4673 | 100.00 | 66.64 | 1490 |
| HSA-MIR-450A-1-3P | 100.00 | 69.33 | 1837 |
| HSA-MIR-5011-5P | 100.00 | 83.46 | 5820 |
| HSA-MIR-6077 | 99.99 | 68.04 | 2299 |
| HSA-MIR-19A-3P | 99.98 | 75.33 | 2762 |
| HSA-MIR-19B-3P | 99.98 | 75.44 | 2754 |
| HSA-MIR-4803 | 99.98 | 71.99 | 3117 |
| HSA-MIR-12136 | 99.98 | 72.81 | 5713 |
| HSA-MIR-4789-5P | 99.98 | 70.76 | 2721 |
| HSA-MIR-4645-5P | 99.98 | 65.81 | 1284 |
| HSA-MIR-520D-5P | 99.98 | 73.34 | 4883 |
| HSA-MIR-524-5P | 99.98 | 73.43 | 4882 |
| HSA-MIR-4482-3P | 99.98 | 72.50 | 3147 |
| HSA-MIR-3148 | 99.97 | 75.06 | 6478 |
| HSA-MIR-8075 | 99.97 | 67.20 | 962 |
| HSA-MIR-548AT-5P | 99.96 | 70.83 | 2666 |
| HSA-MIR-1250-3P | 99.96 | 70.04 | 4038 |
| HSA-MIR-590-3P | 99.96 | 74.34 | 6478 |
| HSA-MIR-2110 | 99.96 | 66.68 | 1930 |
| HSA-MIR-1468-3P | 99.96 | 72.74 | 3797 |
| HSA-LET-7C-3P | 99.95 | 73.42 | 2862 |
| HSA-MIR-651-3P | 99.94 | 73.48 | 5177 |
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Clhc1 | ENSMUSG00000020461 |
| rattus_norvegicus | Clhc1 | ENSRNOG00000004456 |
| drosophila_melanogaster | Chc | FBGN0000319 |
| caenorhabditis_elegans | WBGENE00011867 |
Paralogs (2): CLTCL1 (ENSG00000070371), CLTC (ENSG00000141367)
Protein
Protein identifiers
Clathrin heavy chain linker domain-containing protein 1 — Q8NHS4 (reviewed: Q8NHS4)
All UniProt accessions (6): B5MC48, C9J143, E7EQP3, E7EVC5, Q8NHS4, H7C1D8
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q8NHS4-1 | 1 | yes |
| Q8NHS4-2 | 2 |
RefSeq proteins (10): NP_001129070, NP_001340708, NP_001340709, NP_001340710, NP_001340711, NP_001340712, NP_001340713, NP_001340715, NP_001340716, NP_689598* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR012331 | Clathrin_H-chain_linker | Homologous_superfamily |
| IPR016024 | ARM-type_fold | Homologous_superfamily |
| IPR017212 | CLHC1 | Family |
| IPR032755 | TSNAXIP1_N | Domain |
Pfam: PF13838, PF15739
UniProt features (7 total): sequence variant 4, chain 1, coiled-coil region 1, splice variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8NHS4-F1 | 81.85 | 0.35 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 73 (showing top):
AREB6_01, AACYNNNNTTCCS_UNKNOWN, FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP, TCCCRNNRTGC_UNKNOWN, ASH1L_TARGET_GENES, ATF5_TARGET_GENES, CSHL1_TARGET_GENES, DLX6_TARGET_GENES, ELF2_TARGET_GENES, FEV_TARGET_GENES, HMGA1_TARGET_GENES, HOXB4_TARGET_GENES, HOXC6_TARGET_GENES, IRF5_TARGET_GENES, NCOA2_TARGET_GENES
GO Biological Process (0):
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (0):
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| binding | 1 |
Protein interactions and networks
STRING
1628 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| CLHC1 | ENKD1 | Q9H0I2 | 555 |
| CLHC1 | SCRN1 | Q12765 | 521 |
| CLHC1 | ZDHHC19 | Q8WVZ1 | 492 |
| CLHC1 | LUZP2 | Q86TE4 | 489 |
| CLHC1 | MATCAP2 | Q8NCT3 | 475 |
| CLHC1 | ANKRD55 | Q3KP44 | 454 |
| CLHC1 | C16orf95 | Q9H693 | 446 |
| CLHC1 | SMIM21 | Q3B7S5 | 434 |
| CLHC1 | ZNF621 | Q6ZSS3 | 432 |
| CLHC1 | FAM120AOS | Q5T036 | 430 |
| CLHC1 | WDR93 | Q6P2C0 | 419 |
| CLHC1 | ZNF136 | P52737 | 419 |
| CLHC1 | CALY | Q9NYX4 | 410 |
| CLHC1 | TMEM129 | A0AVI4 | 397 |
| CLHC1 | FERRY3 | Q9NQ89 | 393 |
| CLHC1 | AKAP8 | O43823 | 393 |
IntAct
11 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| LMO2 | CLHC1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CEP170P1 | CLHC1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SGF29 | CLHC1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CLHC1 | CEP170P1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CLHC1 | LMO2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CLHC1 | SGF29 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CLHC1 | rep | psi-mi:“MI:0915”(physical association) | 0.370 |
BioGRID (10): CLHC1 (Two-hybrid), CLHC1 (Two-hybrid), CEP170P1 (Two-hybrid), CLHC1 (Affinity Capture-RNA), CLHC1 (Biochemical Activity), CLHC1 (Affinity Capture-MS), CLHC1 (Affinity Capture-MS), CLHC1 (Affinity Capture-RNA), CLHC1 (Two-hybrid), CLHC1 (Affinity Capture-MS)
ESM2 similar proteins: A0A571BF63, A0A5F8MPE6, A1A535, A8QHQ0, B0W730, O23463, O46470, O54829, O64851, O82645, P49758, P49802, P49803, P49809, Q058N0, Q0VA04, Q14D04, Q28IH8, Q4R6I5, Q4R7Z7, Q502W7, Q569B9, Q5PQS3, Q5SPP5, Q5XG48, Q5XIR8, Q641A2, Q6ZQ18, Q7T0S7, Q86VD1, Q8BG67, Q8BMD7, Q8CDN8, Q8H1E8, Q8IGJ0, Q8N957, Q8NCR3, Q8NHS4, Q96L03, Q96LI9
Diamond homologs: Q4R6I5, Q5M6W3, Q5XIR8, Q8NHS4, P11442, P49951, Q00610, Q68FD5
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
121 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 1 |
| Uncertain significance | 98 |
| Likely benign | 7 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (1)
| Variant ID | HGVS | Classification |
|---|---|---|
| 183280 | NM_152385.4(CLHC1):c.1145G>A (p.Arg382Gln) | Likely pathogenic |
SpliceAI
2572 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 2:55177597:CTTA:C | donor_loss | 1.0000 |
| 2:55177598:TTA:T | donor_loss | 1.0000 |
| 2:55177599:TACCT:T | donor_loss | 1.0000 |
| 2:55177600:A:T | donor_loss | 1.0000 |
| 2:55177601:C:CA | donor_loss | 1.0000 |
| 2:55177601:CCTAT:C | donor_gain | 1.0000 |
| 2:55177686:C:CT | acceptor_gain | 1.0000 |
| 2:55206401:CAT:C | acceptor_gain | 1.0000 |
| 2:55206403:T:TC | acceptor_gain | 1.0000 |
| 2:55208656:T:TA | donor_gain | 1.0000 |
| 2:55209517:C:CC | acceptor_gain | 1.0000 |
| 2:55209620:A:C | donor_gain | 1.0000 |
| 2:55209623:T:TA | donor_gain | 1.0000 |
| 2:55209628:A:AC | donor_gain | 1.0000 |
| 2:55209629:C:CC | donor_gain | 1.0000 |
| 2:55209634:A:C | donor_gain | 1.0000 |
| 2:55209744:G:C | donor_gain | 1.0000 |
| 2:55209827:CATGC:C | acceptor_gain | 1.0000 |
| 2:55209829:TGC:T | acceptor_gain | 1.0000 |
| 2:55209829:TGCC:T | acceptor_loss | 1.0000 |
| 2:55209830:GCCT:G | acceptor_loss | 1.0000 |
| 2:55209832:C:CC | acceptor_gain | 1.0000 |
| 2:55209832:CT:C | acceptor_loss | 1.0000 |
| 2:55209833:T:A | acceptor_loss | 1.0000 |
| 2:55232106:G:GT | donor_gain | 1.0000 |
| 2:55232109:G:GG | donor_gain | 1.0000 |
| 2:55175937:CTTTT:C | acceptor_gain | 0.9900 |
| 2:55175987:C:CC | acceptor_gain | 0.9900 |
| 2:55177600:A:AC | donor_gain | 0.9900 |
| 2:55177601:C:CC | donor_gain | 0.9900 |
AlphaMissense
3894 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 2:55181586:A:G | W389R | 0.974 |
| 2:55181586:A:T | W389R | 0.974 |
| 2:55181594:A:T | V386D | 0.968 |
| 2:55181634:C:G | G373R | 0.966 |
| 2:55181634:C:T | G373R | 0.966 |
| 2:55180627:C:G | A423P | 0.961 |
| 2:55217951:T:A | K75N | 0.959 |
| 2:55217951:T:G | K75N | 0.959 |
| 2:55180626:G:T | A423D | 0.958 |
| 2:55180690:C:A | G402W | 0.956 |
| 2:55175936:A:G | W539R | 0.955 |
| 2:55175936:A:T | W539R | 0.955 |
| 2:55181606:C:G | R382P | 0.952 |
| 2:55206316:A:C | S320R | 0.950 |
| 2:55206316:A:T | S320R | 0.950 |
| 2:55206318:T:G | S320R | 0.950 |
| 2:55181621:C:T | G377E | 0.944 |
| 2:55181633:C:T | G373E | 0.944 |
| 2:55175915:A:G | C546R | 0.941 |
| 2:55180689:C:T | G402E | 0.940 |
| 2:55181618:A:G | L378S | 0.934 |
| 2:55181622:C:G | G377R | 0.931 |
| 2:55181622:C:T | G377R | 0.931 |
| 2:55175924:C:G | A543P | 0.924 |
| 2:55181582:A:T | V390D | 0.924 |
| 2:55222241:A:C | F57L | 0.923 |
| 2:55222241:A:T | F57L | 0.923 |
| 2:55222243:A:G | F57L | 0.923 |
| 2:55206335:G:T | A314D | 0.922 |
| 2:55209774:A:G | L186P | 0.922 |
dbSNP variants (sampled 300 via entrez): RS1000004442 (2:55225614 C>T), RS1000042922 (2:55233105 G>A), RS1000074323 (2:55233227 A>G,T), RS1000115493 (2:55196918 G>A,C), RS1000149447 (2:55232796 C>T), RS1000157806 (2:55222968 C>A,G), RS1000250750 (2:55178768 G>A,T), RS1000256217 (2:55217749 T>C), RS1000257356 (2:55191555 G>A), RS1000297079 (2:55228758 T>A,G), RS1000369081 (2:55217211 A>G), RS1000391704 (2:55181137 T>A), RS1000429465 (2:55172801 T>C), RS1000439078 (2:55223133 G>T), RS1000462233 (2:55186714 G>A)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST009391_1972 | Metabolite levels | 9.000000e-06 |
| GCST012047_14 | Fasting glucose | 8.000000e-07 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0010541 | trimethylamine-N-oxide measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
20 total (human), top 20 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects expression, decreases expression, increases methylation | 3 |
| Cyclosporine | increases expression | 2 |
| tris(1,3-dichloro-2-propyl)phosphate | increases expression | 1 |
| sodium arsenite | decreases expression | 1 |
| avobenzone | decreases expression | 1 |
| jinfukang | decreases expression | 1 |
| Air Pollutants | increases expression, increases abundance | 1 |
| Atrazine | decreases expression | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Cisplatin | decreases expression | 1 |
| Methyl Methanesulfonate | increases expression | 1 |
| Smoke | decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Tretinoin | increases expression | 1 |
| Oxyquinoline | decreases expression | 1 |
| Aflatoxin B1 | increases methylation | 1 |
| Aflatoxin M1 | decreases expression | 1 |
| Cadmium Chloride | decreases expression | 1 |
| Copper Sulfate | decreases expression | 1 |
| Particulate Matter | increases abundance, increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.